P.T

ACTG CROI Presentations Show That Semaglutide Improves Metabolic-Associated Steatotic Liver Disease Among People Living With HIV

Retrieved on: 
Tuesday, March 5, 2024

Yesterday, the SLIM LIVER poster “Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER study” was presented.

Key Points: 
  • Yesterday, the SLIM LIVER poster “Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER study” was presented.
  • Together, these presentations demonstrate that semaglutide was highly effective in improving, and in some cases, resolving completely, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease) among people living with HIV.
  • SLIM LIVER is the first study evaluating semaglutide as a treatment for MASLD among people living with HIV.
  • MASLD is common among people living with HIV and likely acts synergistically with HIV to accelerate liver injury and organ dysfunction.

Net Health's Research Team to Present Data on Key Findings at ACRM Conference

Retrieved on: 
Wednesday, November 9, 2022

PITTSBURGH, Nov. 9, 2022 /PRNewswire/ -- Highlighting the company's industry leadership, Net Health Research and Clinical Outcomes was selected to give three presentations at the 99th American Congress of Rehabilitation Medicine (ACRM) Conference, November 8 – 11 in Chicago.  ACRM is billed as the world's largest interdisciplinary rehabilitation research conference, bringing in top scientists and clinicians globally. 

Key Points: 
  • ACRM is billed as the world's largest interdisciplinary rehabilitation research conference, bringing in top scientists and clinicians globally.
  • Since its founding in 1992, FOTO has been involved in 139 research studies published in peer-reviewed medical or rehabilitation journals.
  • Wednesday, November 9 12:23 12:28 PM
    The presentations will be led by Daniel Deutscher, P.T., Ph.D., Senior Research Scientist for Net Health.
  • "We are excited and honored to have these three studies featured at ACRM," said Deanna Hayes, P.T., D.P.T., M.S., Director of Research and Clinical Outcomes for Net Health.

transcosmos beefs up management structures of overseas subsidiaries to expand its Global Business

Retrieved on: 
Friday, August 19, 2022

TOKYO, Aug. 19, 2022 /PRNewswire-PRWeb/ -- transcosmos inc. hereby announces that the company has beefed up management structures of its overseas subsidiaries in order to further grow its global business. With new representatives in place in its subsidiaries in the U.S., Thailand and Indonesia, transcosmos aims to strengthen its global services and sales capabilities, thereby growing sales overseas.

Key Points: 
  • TOKYO, Aug. 19, 2022 /PRNewswire-PRWeb/ -- transcosmos inc. hereby announces that the company has beefed up management structures of its overseas subsidiaries in order to further grow its global business.
  • With new representatives in place in its subsidiaries in the U.S., Thailand and Indonesia, transcosmos aims to strengthen its global services and sales capabilities, thereby growing sales overseas.
  • Kiyonori Takechi has led transcosmos's local business in Thailand as a Managing Director of transcosmos (Thailand) Co., Ltd. since its launch of local business in 2015.
  • transcosmos continued to expand its global business, and today, the company has presence in 27 countries and regions outside of Japan, serving clients from 103 locations.